Back to News
Market Impact: 0.55

Morgan Stanley says buy these five stocks that are set to rally

MSCHWYULTANUGTLSCPNGFLS
Analyst InsightsCompany FundamentalsCorporate Guidance & OutlookM&A & RestructuringTax & TariffsCurrency & FXMarket Technicals & Flows
Morgan Stanley says buy these five stocks that are set to rally

Morgan Stanley has identified five stocks as top picks with significant upside potential: Chart Industries, Ulta Beauty, Coupang, Chewy, and NuBank. The firm highlights Chart Industries' post-merger growth and defensive qualities, Ulta's undervalued position amid improving industry trends, and Coupang's competitive advantage in Korean e-commerce. Additionally, Chewy presents an underpriced opportunity in the vet clinic market, while NuBank is poised for substantial market share gains in Brazil's payroll loan segment, collectively offering compelling investment theses.

Analysis

Morgan Stanley has identified five overweight-rated stocks, each with a distinct, catalyst-driven investment thesis. For Chart Industries (GTLS), the recent merger agreement with Flowserve is seen as a pivotal event that accelerates strategic initiatives and offers significant deal-related upside, complementing what is already viewed as a compelling organic growth story. The stock, up 18% in the past year, is also positioned as a defensive holding. In the consumer space, Ulta Beauty (ULTA) is considered undervalued, with analysts believing its current guidance is conservative, setting a low bar for potential earnings beats in 2H25, supported by improving sector trends and minimal tariff risk. Similarly, Korean e-commerce leader Coupang (CPNG) is highlighted for its sustained market share gains, driven by a superior integrated fulfillment network, insulation from tariff risks, and benefits from a weaker US dollar; its valuation remains attractive despite a 40% stock increase in the past three months. Chewy (CHWY) presents a unique growth vector through its expansion into the $40 billion veterinary clinic market, which Morgan Stanley frames as an underpriced call option with a potential 2.5x to 5.0x return on investment per clinic. Finally, Nu Holdings (NU) offers a contrarian opportunity, with analysts forecasting it will capture a 10% market share in Brazil's payroll loan segment by 2026, substantially higher than the 3-4% consensus estimate.

AllMind AI Terminal